Symbols / KIDS Stock $16.21 -0.98% OrthoPediatrics Corp.

Healthcare • Medical Devices • United States • NGM
KIDS (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: SMA 50: SMA 200:
About

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity in children; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, Mitchell Ponseti, VerteGlideTM, and Boston Brace 3D. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

Stock Fundamentals
Scroll to Statements
Market Cap 416.37M Enterprise Value 460.90M Income -39.65M Sales 236.35M Book/sh 13.81 Cash/sh 2.41
Dividend Yield Payout 0.00% Employees 602 IPO P/E Forward P/E -23.32
PEG P/S 1.76 P/B 1.17 P/C EV/EBITDA -58.49 EV/Sales 1.95
Quick Ratio 2.48 Current Ratio 5.55 Debt/Eq 32.31 LT Debt/Eq EPS (ttm) -1.69 EPS next Y -0.69
EPS Growth Revenue Growth 17.00% Earnings 2026-04-30 ROA -3.69% ROE -11.31% ROIC
Gross Margin 73.05% Oper. Margin -8.94% Profit Margin -16.78% Shs Outstand 25.69M Shs Float 15.50M Short Float 5.63%
Short Ratio 5.36 Short Interest 52W High 23.70 52W Low 14.91 Beta 1.16 Avg Volume 148.30K
Volume 84.57K Target Price $24.89 Recom Buy Prev Close $16.37 Price $16.21 Change -0.98%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$24.89
Mean price target
2. Current target
$16.21
Latest analyst target
3. DCF / Fair value
$-7.02
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$16.21
Low
$20.00
High
$34.00
Mean
$24.89

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-02 main Truist Securities Hold → Hold $20
2026-02-27 main Needham Buy → Buy $30
2026-02-27 main BTIG Buy → Buy $24
2026-01-27 init TD Cowen — → Buy $23
2025-12-10 init Canaccord Genuity — → Buy $24
2025-10-29 main Needham Buy → Buy $26
2025-10-29 reit BTIG Buy → Buy $23
2025-10-10 main Lake Street Buy → Buy $34
2025-10-10 main Stifel Buy → Buy $20
2025-10-10 main JMP Securities Market Outperform → Market Outperform $25
2025-10-10 main Piper Sandler Overweight → Overweight $22
2025-10-10 main BTIG Buy → Buy $23
2025-08-08 main JMP Securities Market Outperform → Market Outperform $35
2025-08-06 main BTIG Buy → Buy $39
2025-05-08 main Piper Sandler Overweight → Overweight $30
2025-05-08 reit Needham Buy → Buy $42
2025-04-11 main Truist Securities Hold → Hold $24
2025-04-09 reit Needham Buy → Buy $42
2025-04-07 init Lake Street — → Buy $37
2025-03-21 reit Citizens Capital Markets Market Outperform → Market Outperform $50
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-16 HAUSER JOSEPH W Officer 8,596 $17.25 $148,281
2026-03-16 HITE FRED L Chief Operating Officer 12,993 $17.25 $224,129
2026-03-16 BAILEY DAVID R Chief Executive Officer 19,535 $17.25 $336,979
2026-03-16 GERRITZEN DANIEL J. General Counsel 8,614 $17.25 $148,592
2026-03-16 ODLE GREGORY A Officer 8,433 $17.25 $145,469
2026-03-13 HAUSER JOSEPH W Officer 65,700 $0.00 $0
2026-03-13 HITE FRED L Chief Operating Officer 77,405 $0.00 $0
2026-03-13 GERRITZEN DANIEL J. General Counsel 47,380 $0.00 $0
2026-03-13 ODLE GREGORY A Officer 47,380 $0.00 $0
2025-12-29 BAILEY DAVID R Chief Executive Officer 1,600 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
236.35
+15.45%
204.73
+37.65%
148.73
+21.62%
122.29
Operating Revenue
236.35
+15.45%
204.73
+37.65%
148.73
+21.62%
122.29
Cost Of Revenue
63.69
+13.47%
56.13
+49.76%
37.48
+18.50%
31.63
Reconciled Cost Of Revenue
63.69
+13.47%
56.13
+49.76%
37.48
+18.50%
31.63
Gross Profit
172.66
+16.19%
148.60
+33.57%
111.25
+22.71%
90.66
Operating Expense
201.66
+13.22%
178.12
+30.00%
137.02
+21.85%
112.45
Research And Development
9.10
-17.51%
11.03
+1.28%
10.89
+28.90%
8.45
Selling General And Administration
192.56
+15.25%
167.09
+32.48%
126.12
+21.28%
104.00
Selling And Marketing Expense
72.73
+13.11%
64.30
+21.72%
52.82
+14.60%
46.09
General And Administrative Expense
119.83
+16.58%
102.79
+40.23%
73.30
+26.59%
57.90
Other Gand A
119.83
+16.58%
102.79
+40.23%
73.30
+26.59%
57.90
Total Expenses
265.35
+13.28%
234.25
+34.24%
174.50
+21.11%
144.08
Operating Income
-29.00
+1.77%
-29.52
-14.57%
-25.77
-18.25%
-21.79
Total Operating Income As Reported
-39.24
-12.08%
-35.01
-30.87%
-26.75
-5.32%
-25.40
EBITDA
-7.88
+24.53%
-10.44
-24.58%
-8.38
+3.57%
-8.69
Normalized EBITDA
2.36
+236.99%
-1.72
+83.40%
-10.38
+66.54%
-31.01
Reconciled Depreciation
21.12
+10.69%
19.08
+9.75%
17.39
+32.72%
13.10
EBIT
-29.00
+1.77%
-29.52
-14.57%
-25.77
-18.25%
-21.79
Total Unusual Items
-10.24
-17.43%
-8.72
-537.04%
2.00
-91.06%
22.32
Total Unusual Items Excluding Goodwill
-10.24
-17.43%
-8.72
-537.04%
2.00
-91.06%
22.32
Special Income Charges
-10.24
-17.43%
-8.72
-537.04%
2.00
-91.06%
22.32
Other Special Charges
3.23
Impairment Of Capital Assets
4.64
+152.61%
1.84
+86.40%
0.98
-72.71%
3.61
Restructuring And Mergern Acquisition
5.60
+53.33%
3.65
+222.58%
-2.98
+88.51%
-25.93
Net Income
-39.65
-4.83%
-37.82
-80.33%
-20.97
-1767.25%
1.26
Pretax Income
-39.19
+6.54%
-41.93
-96.74%
-21.31
-477.72%
-3.69
Net Non Operating Interest Income Expense
-6.00
-128.77%
-2.62
-1423.74%
0.20
+108.17%
-2.42
Interest Expense Non Operating
2.42
Net Interest Income
-6.00
-128.77%
-2.62
-1423.74%
0.20
+108.17%
-2.42
Interest Expense
2.42
Other Income Expense
-4.19
+57.16%
-9.79
-329.96%
4.26
-79.26%
20.52
Other Non Operating Income Expenses
6.05
+666.10%
-1.07
-147.24%
2.26
+225.89%
-1.80
Tax Provision
0.46
+111.20%
-4.11
-1115.09%
-0.34
+93.17%
-4.95
Tax Rate For Calcs
0.00
+114.29%
0.00
+512.50%
0.00
-92.38%
0.00
Tax Effect Of Unusual Items
-2.15
-151.64%
-0.85
-2776.89%
0.03
-99.32%
4.69
Net Income Including Noncontrolling Interests
-39.65
-4.83%
-37.82
-80.33%
-20.97
-1767.25%
1.26
Net Income From Continuing Operation Net Minority Interest
-39.65
-4.83%
-37.82
-80.33%
-20.97
-1767.25%
1.26
Net Income From Continuing And Discontinued Operation
-39.65
-4.83%
-37.82
-80.33%
-20.97
-1767.25%
1.26
Net Income Continuous Operations
-39.65
-4.83%
-37.82
-80.33%
-20.97
-1767.25%
1.26
Net Income Discontinuous Operations
Normalized Income
-31.56
-5.35%
-29.96
-30.61%
-22.94
-40.07%
-16.38
Net Income Common Stockholders
-39.65
-4.83%
-37.82
-80.33%
-20.97
-1798.30%
1.24
Otherunder Preferred Stock Dividend
0.00
0.00
0.00
-100.00%
0.02
Diluted EPS
-1.69
-3.05%
-1.64
-78.26%
-0.92
-1633.33%
0.06
Basic EPS
-1.69
-3.05%
-1.64
-78.26%
-0.92
-1633.33%
0.06
Basic Average Shares
23.46
+1.65%
23.08
+1.77%
22.68
+9.52%
20.70
Diluted Average Shares
23.46
+1.65%
23.08
+1.77%
22.68
+8.25%
20.95
Diluted NI Availto Com Stockholders
-39.65
-4.83%
-37.82
-80.33%
-20.97
-1798.30%
1.24
Total Other Finance Cost
6.00
+128.77%
2.62
+1423.74%
-0.20
-108.17%
2.42
Line Item Trend 2023-12-31
Total Assets
438.75
Current Assets
226.50
Cash Cash Equivalents And Short Term Investments
80.31
Cash And Cash Equivalents
31.05
Cash Financial
31.05
Other Short Term Investments
49.25
Receivables
34.62
Accounts Receivable
34.62
Gross Accounts Receivable
35.99
Allowance For Doubtful Accounts Receivable
-1.37
Inventory
105.85
Prepaid Assets
Restricted Cash
1.97
Other Current Assets
3.75
Total Non Current Assets
212.25
Net PPE
41.05
Gross PPE
80.64
Accumulated Depreciation
-39.59
Properties
0.00
Land And Improvements
1.73
Buildings And Improvements
5.87
Machinery Furniture Equipment
11.65
Construction In Progress
5.52
Other Properties
55.87
Goodwill And Other Intangible Assets
168.26
Goodwill
83.70
Other Intangible Assets
84.56
Other Non Current Assets
2.94
Total Liabilities Net Minority Interest
61.72
Current Liabilities
41.67
Payables And Accrued Expenses
29.84
Payables
22.80
Accounts Payable
12.65
Other Payable
10.15
Current Accrued Expenses
7.05
Pensionand Other Post Retirement Benefit Plans Current
4.28
Current Debt And Capital Lease Obligation
0.15
Current Debt
0.15
Other Current Borrowings
0.15
Other Current Liabilities
7.39
Total Non Current Liabilities Net Minority Interest
20.05
Long Term Debt And Capital Lease Obligation
9.91
Long Term Debt
9.91
Tradeand Other Payables Non Current
3.55
Non Current Deferred Liabilities
5.48
Non Current Deferred Taxes Liabilities
5.48
Other Non Current Liabilities
1.11
Stockholders Equity
377.02
Common Stock Equity
377.02
Capital Stock
0.01
Common Stock
0.01
Share Issued
23.38
Ordinary Shares Number
23.38
Treasury Shares Number
0.00
Additional Paid In Capital
580.29
Retained Earnings
-197.74
Gains Losses Not Affecting Retained Earnings
-5.53
Other Equity Adjustments
-5.53
Total Equity Gross Minority Interest
377.02
Total Capitalization
386.93
Working Capital
184.83
Invested Capital
387.08
Total Debt
10.06
Net Debt
Net Tangible Assets
208.76
Tangible Book Value
208.76
Notes Receivable
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-4.85
+82.07%
-27.05
-0.01%
-27.05
-24.26%
-21.77
Cash Flow From Continuing Operating Activities
-4.85
+82.07%
-27.05
-0.01%
-27.05
-24.26%
-21.77
Cash From Discontinued Operating Activities
Net Income From Continuing Operations
-39.65
-4.83%
-37.82
-80.33%
-20.97
-1767.25%
1.26
Depreciation Amortization Depletion
21.12
+10.69%
19.08
+9.75%
17.39
+32.72%
13.10
Depreciation
10.24
+43.74%
7.12
Amortization Cash Flow
7.15
+19.61%
5.98
Depreciation And Amortization
21.12
+10.69%
19.08
+9.75%
17.39
+32.72%
13.10
Amortization Of Intangibles
7.15
+19.61%
5.98
Other Non Cash Items
0.33
-55.66%
0.75
+146.70%
-1.61
+93.19%
-23.62
Stock Based Compensation
17.78
+31.22%
13.55
+28.71%
10.53
+57.60%
6.68
Asset Impairment Charge
6.51
+254.68%
1.84
+86.40%
0.98
-72.71%
3.61
Deferred Tax
-0.15
+96.77%
-4.74
-307.22%
-1.16
+76.89%
-5.03
Deferred Income Tax
-0.15
+96.77%
-4.74
-307.22%
-1.16
+76.89%
-5.03
Operating Gains Losses
3.23
Change In Working Capital
-10.79
+52.95%
-22.93
+28.77%
-32.20
-81.33%
-17.76
Change In Receivables
-9.37
-97.22%
-4.75
+51.16%
-9.72
-144.14%
-3.98
Changes In Account Receivables
-9.37
-97.22%
-4.75
+51.16%
-9.72
-144.14%
-3.98
Change In Inventory
-8.47
+35.83%
-13.20
+49.78%
-26.28
-55.15%
-16.94
Change In Prepaid Assets
0.41
+126.52%
-1.56
-1760.64%
0.09
+118.58%
-0.51
Change In Payables And Accrued Expense
9.41
+351.54%
-3.74
-144.86%
8.34
+166.12%
3.13
Change In Accrued Expense
1.25
+132.40%
0.54
-92.16%
6.85
+104.90%
3.34
Change In Payable
8.17
+290.82%
-4.28
-387.06%
1.49
+813.40%
-0.21
Change In Account Payable
8.17
+290.82%
-4.28
-387.06%
1.49
+813.40%
-0.21
Change In Other Working Capital
-2.79
-984.44%
0.32
+106.80%
-4.63
-963.99%
0.54
Investing Cash Flow
-43.63
-231.48%
-13.16
-131.58%
41.68
+136.76%
-113.37
Cash Flow From Continuing Investing Activities
-43.63
-231.48%
-13.16
-131.58%
41.68
+136.76%
-113.37
Net PPE Purchase And Sale
-11.11
+22.11%
-14.26
+15.49%
-16.88
-68.26%
-10.03
Purchase Of PPE
-11.11
+22.11%
-14.26
+15.49%
-16.88
-68.26%
-10.03
Capital Expenditure
-11.11
+22.11%
-14.26
+15.49%
-16.88
-68.26%
-10.03
Net Investment Purchase And Sale
-17.02
-170.29%
24.21
-61.08%
62.20
+198.34%
-63.25
Purchase Of Investment
-17.02
+33.65%
-25.65
+49.42%
-50.71
+53.95%
-110.12
Sale Of Investment
0.00
-100.00%
49.85
-55.84%
112.90
+140.88%
46.87
Net Business Purchase And Sale
-15.50
+32.91%
-23.11
-646.11%
-3.10
+92.27%
-40.09
Purchase Of Business
-15.50
+32.91%
-23.11
-646.11%
-3.10
+92.27%
-40.09
Net Intangibles Purchase And Sale
-2.11
0.00
Purchase Of Intangibles
-2.11
0.00
Net Other Investing Changes
-0.55
Financing Cash Flow
23.98
-54.88%
53.13
+627.78%
7.30
-94.63%
135.97
Cash Flow From Continuing Financing Activities
23.98
-54.88%
53.13
+627.78%
7.30
-94.63%
135.97
Net Issuance Payments Of Debt
24.84
-59.38%
61.15
+558.94%
9.28
+6873.72%
-0.14
Issuance Of Debt
25.00
-66.00%
73.53
+680.27%
9.42
-69.60%
31.00
Repayment Of Debt
-0.16
+98.72%
-12.38
-8499.31%
-0.14
+99.54%
-31.14
Long Term Debt Issuance
25.00
-66.00%
73.53
+680.27%
9.42
-69.60%
31.00
Long Term Debt Payments
-0.16
+98.72%
-12.38
-8499.31%
-0.14
+99.54%
-31.14
Net Long Term Debt Issuance
24.84
-59.38%
61.15
+558.94%
9.28
+6873.72%
-0.14
Net Common Stock Issuance
0.00
0.00
-100.00%
139.28
Proceeds From Stock Option Exercised
0.00
0.00
-100.00%
0.02
-66.67%
0.06
Net Other Financing Charges
-0.87
+89.18%
-8.02
-300.75%
-2.00
+38.16%
-3.23
Changes In Cash
-24.50
-289.59%
12.93
-41.07%
21.93
+2520.31%
0.84
Effect Of Exchange Rate Changes
0.35
+298.86%
-0.17
-127.65%
0.63
+2.26%
0.62
Beginning Cash Position
45.78
+38.60%
33.03
+215.69%
10.46
+16.17%
9.01
End Cash Position
21.62
-52.77%
45.78
+38.60%
33.03
+215.69%
10.46
Free Cash Flow
-15.96
+61.36%
-41.31
+5.95%
-43.92
-38.14%
-31.80
Interest Paid Supplemental Data
6.52
+136.77%
2.75
+6452.38%
0.04
-94.00%
0.70
Common Stock Issuance
0.00
0.00
-100.00%
139.28
Issuance Of Capital Stock
0.00
0.00
-100.00%
139.28
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category